Sign in
|
Join
|
Help
in
Current Tags
(Entire Site)
Home
Blogs
Directory
Feeds
All Posts (RSS)
All Posts (OPML)
Filters
All Posts
Internal Posts
External Posts
Photos
Directory
Feeds
All Posts (RSS)
Forums
Directory
Feeds
All Posts (RSS)
Filters
Active Threads
Forum Subscriptions
My Forums
Posts Containing Video
Unanswered Posts
Unread Posts
Downloads
Tags
Users
Control Panel
Blogs
Write a new post...
Photos
Post a new photo...
arachnode.net
»
All Tags
»
Drugs (Pharmaceuticals)
(
RSS
)
Browse by Tags
Abbott Laboratories Inc|ABT|NYSE
Accidents and Safety
Acquired Immune Deficiency Syndrome
Advertising and Marketing
Aged
Alaska
Alcoholic Beverages
Alcon Incorporated|ACL|NYSE
Allergies
Alzheimer's Disease
American Academy of Pediatrics
American Arbitration Assn
Amgen Inc|AMGN|NASDAQ
Amniocentesis
Amylin Pharmaceuticals Incorporated|AMLN|NASDAQ
Anemia
Anesthesia and Anesthetics
Antibiotics
Antidepressants
Antitrust Actions and Laws
Apotex Inc
Arthritis and Rheumatism
AstraZeneca|AZN|NYSE
Avastin (Drug)
Avista Capital Partners
Ayd, Frank J. Jr
Babies
Baxter International Inc|BAX|NYSE
Bayer AG|BAY|NYSE
Berger, Dr. Frank M.
Beta Blockers
Bextra (Drug)
Biogen Idec Incorporated|BIIB|NASDAQ
Biology and Biochemistry
Biotechnology
Birth Control and Family Planning
Bisphosphonates
Blacks
Blood
Blood Clots
Bodnar, Andrew G
Bone Fractures
Bones
Books and Literature
Botox (Drug)
Brain
Breast
Bristol-Myers Squibb Co|BMY|NYSE
Budgets and Budgeting
Bush, George W
Byetta
Byetta (Drug)
California
Cancer
Children and Youth
China
Cholesterol
Company Reports
Crohn's Disease
CVS Corporation|CVS|NYSE
Death and Dying
Deaths (Obituaries)
Decisions and Verdicts
DeLauro, Rosa
Dementia
Depression (Mental)
Diabetes
Diet and Nutrition
Dingell, John D
DNA (Deoxyribonucleic Acid)
Doctors
Drug Abuse and Traffic
Drugstores
Education and Schools
Elan Corporation Plc|ELN|NYSE
European Medicines Agency
European Union
Exercise
Express Scripts Incorporated|ESRX|NASDAQ
Food and Drug Administration
Food Contamination and Poisoning
Genentech Inc|DNA|NYSE
Generic and Brand Name Products
Genetics and Heredity
GlaxoSmithKline PLC|GSK|NYSE
GlaxoSmithKline|GSK|NYSE
Hazardous and Toxic Substances
Health Insurance and Managed Care
Heart
Heparin (Drug)
House of Representatives
ImClone Systems Incorporated|IMCL|NASDAQ
Insurance
International Trade and World Market
Inventions and Patents
Johnson & Johnson Inc
Lilly, Eli, & Co
Malaria
Medicaid
Medicare
Medicine and Health
Mental Health and Disorders
Merck & Company Inc
Mergers, Acquisitions and Divestitures
Methadone
Multiple Sclerosis
Muscles
Muscular Dystrophy
Myriad Genetics Incorporated|MYGN|NASDAQ
New England Journal of Medicine
Novartis|NVS|NYSE
Obesity
Osteoporosis
Pfizer Inc|PFE|NYSE
Prices (Fares, Fees and Rates)
Ranbaxy Laboratories
Rebates
Recalls and Bans of Products
Research
Resveratrol (Chemical)
Retail Stores and Trade
Roche Holding Ltd|RHHBY|other-OTC
Sales
Schering Plough Corp|SGP|NYSE
Schizophrenia
Sciele Pharma , Incorporated|SCRX|NASDAQ
Science and Technology
Sedatives
Senate
Sirtris Pharmaceuticals , Incorporated|SIRT|NASDAQ
Skin
Statins (Cholesterol-Lowering Drugs)
Stocks and Bonds
Suicides and Suicide Attempts
Suits and Litigation
Supreme Court
Tests and Testing
Third World and Developing Countries
Tysabri (Drug)
United States
United States Politics and Government
Vaccination and Immunization
Viagra (Drug)
Vytorin (Drug)
Wall Street (NYC)
Wines
Women
Wyeth|WYE|NYSE
Zetia (Drug)
Zyprexa (Drug)
Judge to Unseal Documents on the Eli Lilly Drug Zyprexa
A federal judge in Brooklyn decided to unseal confidential materials about Eli Lilly’s top-selling antipsychotic drug, citing questions about the way drugs are approved for new uses.
Posted to
partners.userland.com
(Weblog)
by
Anonymous
on 09-05-2008
Judge to Unseal Documents on the Eli Lilly Drug Zyprexa
A federal judge in Brooklyn decided to unseal confidential materials about Eli Lilly’s top-selling antipsychotic drug, citing questions about the way drugs are approved for new uses.
Posted to
nytimes.com
(Weblog)
by
Anonymous
on 09-05-2008
Arthritis Drugs Linked to Risks From Infection
Federal officials ordered stronger warnings on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.
Posted to
partners.userland.com
(Weblog)
by
Anonymous
on 09-04-2008
Arthritis Drugs Linked to Risks From Infection
Federal officials ordered stronger warnings on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.
Posted to
nytimes.com
(Weblog)
by
Anonymous
on 09-04-2008
Stronger Warnings Ordered on Arthritis Drugs
Federal health regulators ordered new warning language for prescription drugs to treat rheumatoid arthritis, Crohn’s disease and other conditions after a dozen patients died.
Posted to
partners.userland.com
(Weblog)
by
Anonymous
on 09-04-2008
Stronger Warnings Ordered on Arthritis Drugs
Federal health regulators ordered new warning language for prescription drugs to treat rheumatoid arthritis, Crohn’s disease and other conditions after a dozen patients died.
Posted to
nytimes.com
(Weblog)
by
Anonymous
on 09-04-2008
F.D.A. Orders Stronger Warnings on Arthritis Drugs
Four medications used to treat rheumatoid arthritis can increase the risk of contracting fatal fungal infections, the agency said.
Posted to
partners.userland.com
(Weblog)
by
Anonymous
on 09-04-2008
F.D.A. Orders Stronger Warnings on Arthritis Drugs
Four medications used to treat rheumatoid arthritis can increase the risk of contracting fatal fungal infections, the agency said.
Posted to
nytimes.com
(Weblog)
by
Anonymous
on 09-04-2008
Pfizer Acquires Rights to Alzheimer’s Drug
Pfizer said that it was acquiring the rights to Dimebon, a promising experimental drug for Alzheimer’s disease, from Medivation for as much as $725 million.
Posted to
partners.userland.com
(Weblog)
by
Anonymous
on 09-03-2008
Pfizer Acquires Rights to Alzheimer’s Drug
Pfizer said that it was acquiring the rights to Dimebon, a promising experimental drug for Alzheimer’s disease, from Medivation for as much as $725 million.
Posted to
nytimes.com
(Weblog)
by
Anonymous
on 09-03-2008
Page 1 of 32 (314 items) 1
2
3
4
5
Next >
...
Last »
This work is licensed under a
Creative Commons Attribution 3.0 United States License
.
* WebCrawler descriptions and academia provided in part by:
wikipedia.org
* All rights reserved to the original authors.
arachnode.net - a .NET web crawler written in C# using SQL 2005